Trump seeks to limit direct-to-consumer pharmaceutical advertising, potentially affecting Hims & Hers Health.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 09 2025
0mins
Source: MarketWatch
Trump Administration's New Memorandum: The Trump administration has introduced a memorandum aimed at restricting direct-to-consumer advertising for pharmaceuticals, citing concerns over misleading advertisements.
Concerns from Medical Professionals: Doctors have expressed frustration with these ads, claiming they distort patient relationships and often fail to adequately disclose potential side effects.
Analyst Views on PJP
Wall Street analysts forecast PJP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PJP is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 105.950
Low
Averages
High
Current: 105.950
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
